Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu-Dong Zhang

Showing results (1-10 of 354) with videos related to

Pageof 36
Sort By:
Scientific Reports|June 6, 2024
The minimum mass ratio of W UMa-type contact binaries-a new calculationXu-Dong Zhang
Pigment Cell & Melanoma Research|May 15, 2008
Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanomaPeter Hersey, Xu Dong Zhang
Journal of Cellular Physiology|May 27, 2003
Overcoming resistance of cancer cells to apoptosisPeter Hersey, Xu Dong Zhang
Cancer Immunology, Immunotherapy : CII|June 25, 2009
Treatment combinations targeting apoptosis to improve immunotherapy of melanomaPeter Hersey, Xu Dong Zhang
Cancer Biology & Therapy|November 14, 2003
Resistance of follicular lymphoma cells to chemotherapy is more than just BCL-2Peter Hersey, Xu Dong Zhang
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|November 9, 2010
[Diagnosis and treatment of 78 cases of aged epistaxis]Shu-xia Yao, Xu-dong Zhang
Molecular Cancer Therapeutics|April 14, 2005
Variable expression of protein kinase C epsilon in human melanoma cells regulates sensitivity to TRAIL-induced apoptosisSusan Gillespie, Xu Dong Zhang, Peter Hersey
Advances in Experimental Medicine and Biology|April 29, 2008
Overcoming resistance to apoptosis in cancer therapyPeter Hersey, Xu Dong Zhang, Nizar Mhaidat
Anti-Cancer Agents in Medicinal Chemistry|January 9, 2013
The application of fungal β-glucans for the treatment of colon cancerJiezhong Chen, Xu Dong Zhang, Zhengyi Jiang
Science Signaling|September 3, 2015
Dissecting the signaling pathways that mediate cancer in PTEN and LKB1 double-knockout miceJiezhong Chen, Xu Dong Zhang, Christopher Proud
Pageof 36

Showing results (1-10 of 354) with videos related to

Sort By:
Pageof 36
Scientific Reports|June 6, 2024
The minimum mass ratio of W UMa-type contact binaries-a new calculationXu-Dong Zhang
Pigment Cell & Melanoma Research|May 15, 2008
Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanomaPeter Hersey, Xu Dong Zhang
Journal of Cellular Physiology|May 27, 2003
Overcoming resistance of cancer cells to apoptosisPeter Hersey, Xu Dong Zhang
Cancer Immunology, Immunotherapy : CII|June 25, 2009
Treatment combinations targeting apoptosis to improve immunotherapy of melanomaPeter Hersey, Xu Dong Zhang
Cancer Biology & Therapy|November 14, 2003
Resistance of follicular lymphoma cells to chemotherapy is more than just BCL-2Peter Hersey, Xu Dong Zhang
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|November 9, 2010
[Diagnosis and treatment of 78 cases of aged epistaxis]Shu-xia Yao, Xu-dong Zhang
Molecular Cancer Therapeutics|April 14, 2005
Variable expression of protein kinase C epsilon in human melanoma cells regulates sensitivity to TRAIL-induced apoptosisSusan Gillespie, Xu Dong Zhang, Peter Hersey
Advances in Experimental Medicine and Biology|April 29, 2008
Overcoming resistance to apoptosis in cancer therapyPeter Hersey, Xu Dong Zhang, Nizar Mhaidat
Anti-Cancer Agents in Medicinal Chemistry|January 9, 2013
The application of fungal β-glucans for the treatment of colon cancerJiezhong Chen, Xu Dong Zhang, Zhengyi Jiang
Science Signaling|September 3, 2015
Dissecting the signaling pathways that mediate cancer in PTEN and LKB1 double-knockout miceJiezhong Chen, Xu Dong Zhang, Christopher Proud
Pageof 36